NASDAQ | ETF
The fund invests more than 80% of its total assets in the securities of the underlying index.
The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| 4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 3.87% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.24% |
| ALC | Alcon AG | Healthcare | Medical Instruments & Supplies | 3.15% |
| RO | Roche Holding AG | Healthcare | Drug Manufacturers - General | 3.11% |
| WELL | Welltower Inc | Real Estate | REIT - Healthcare Facilities | 3.02% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 3.00% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.97% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.96% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 2.96% |
| 0QIU | Novo Nordisk A/S Class B | 2.94% | ||
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.90% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.89% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 2.87% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 2.83% |
| UCB | UCB SA | Healthcare | Biotechnology | 2.81% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.81% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.78% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.65% |
| VTR | Ventas Inc | Real Estate | REIT - Healthcare Facilities | 2.45% |
| 4543 | Terumo Corp. | Healthcare | Medical Instruments & Supplies | 2.39% |